Description
The effective ingredient of 98% wall breaking rate is 75 times higher than that of general Ganoderma
The effectiveness of Ganoderma lucidum spores depends on the breaking rate of the wall. Taking the unbroken spores, only the active ingredients of 12% ** are absorbed by the body. On the contrary, the spore absorption rate after breaking the wall was above 95% ^. The spores of Ganoderma lucidum Ganoderma lucidum adopt patented technology, through the low temperature enzymolysis method, and the local university has proved that the wall breaking rate reaches 98% ** completely, retaining the active ingredients of the spores completely, allowing the gastrointestinal tract to be directly absorbed and exerting the strongest health care effect.

High breaking wall and strong immunity
Ganoderma lucidum spores must be broken before the body can absorb it, because the hard chitin shell tightly wraps the ingredients in the ganoderma spores, which affects the body’s absorption. Recent studies have shown that reducing sugars and multi-enzymes in broken spores are easier to extract than ordinary spores, and broken spores have a stronger effect than unbroken spores. It contains Ganoderma lucidum polysaccharides, triterpenes, adenosine, organic germanium, enzymes and various trace elements. The above ingredients have been proven to effectively enhance the body’s immunity, assist stubborn diseases and regulate the functions of various parts of the body.

Unbroken Ganoderma spores-microscope image
Unbroken Ganoderma spores-microscope image

98% Broken Ganoderma spores-micrograph
98% Broken Ganoderma spores-micrograph
Incorporating medicine to induce “Mushroom” Ganoderma to full effect
Maitake is the golden key to start the door of immunity. It can enhance the absorption of Ganoderma spores, and exert the effect of its 98% Ganoderma spores to the fullest extent, improving the immunity. The β-glucan contained in Maitake helps the immune system fight bacteria quickly and repair damaged tissues.
Reviews
There are no reviews yet.